| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.4M | — | -59.3% |
| Cost of Revenue | $2.4M | — | -39.8% |
| Gross Profit | $991K | — | -77.2% |
| R&D Expense | $1.6M | — | -39.0% |
| SG&A Expense | $2.0M | — | -7.5% |
| Operating Income | -$4.4M | — | -64.7% |
| Pre-tax Income | -$4.2M | — | -71.9% |
| Income Tax | -$1.6M | — | -1560.9% |
| Net Income | -$2.6M | — | -2.1% |
| EPS (Basic) | -$0.16 | — | +0.0% |
| EPS (Diluted) | -$0.16 | — | +0.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $18.3M | -17.0% | -3.9% |
| Accounts Receivable | $3.6M | -40.8% | -80.1% |
| Inventory | $16.5M | +13.3% | +66.3% |
| Current Assets | $42.6M | -7.2% | -21.4% |
| Total Assets | $51.5M | -2.8% | -14.4% |
| Current Liabilities | $5.9M | +24.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.8M | — | -40.2% |
| Capital Expenditures | $3K | — | -57.1% |
| Investing Cash Flow | -$3K | — | +57.1% |
| Financing Cash Flow | -$300K | — | +0.0% |
| Free Cash Flow | -$3.8M | — | -39.9% |
| -12.9% |
| Total Liabilities | $6.0M | +21.5% | -16.3% |
| Stockholders' Equity | $45.5M | -5.3% | -14.1% |